Financial Instruments and Fair Value Measurements - Narrative (Details) - USD ($) $ in Millions |
3 Months Ended | |
|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
|
| Concentration Risk [Line Items] | ||
| Interest income | $ 0.9 | $ 1.8 |
| Impairment of property, plant and equipment | $ 0.0 | 10.4 |
| Cost of products sold | ||
| Concentration Risk [Line Items] | ||
| Impairment of property, plant and equipment | 6.1 | |
| Research and development expense | ||
| Concentration Risk [Line Items] | ||
| Impairment of property, plant and equipment | $ 4.3 | |
| Customer Concentration Risk | Revenues | Three Customers In Aggregate | ||
| Concentration Risk [Line Items] | ||
| Concentration risk percentage | 38.10% | |
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of interest income earned from interest bearing assets classified as other. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The charge against earnings resulting from the aggregate write down of tangible assets from their carrying value to their fair value. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|